In this systematic review and meta-analysis, researchers examined outcomes among advanced ovarian cancer patients who ...

Fuzuloparib monotherapy significantly improved PFS in advanced ovarian cancer, but adding apatinib did not enhance outcomes. The study included patients with newly diagnosed ovarian, fallopian tube, ...

A retrospective study compared progression-free and overall survival of hyperthermic intraperitoneal chemotherapy with conventional intraperitoneal chemotherapy in patients with ovarian cancer.

Early evidence suggests safety, efficacy, while awaiting data on durability in broader pop ...

In the evolving landscape of metastatic colorectal cancer, managing patients with RAS/BRAF wild-type tumors remains a ...

The annual report from the American Cancer Society shared good news about the fight against the disease.

The five-year survival rate for all cancers combined in the US reached a landmark 70% for Americans diagnosed between 2015 ...

An annual report from the American Cancer Society shows that, for the first time, over 70% of Americans diagnosed with cancer ...

A record 70% of cancer patients are living five years past their diagnosis, according to a report released Tuesday by the ...

Lung cancer incidence rates in the United States have undergone a significant transformation over the last several decades, ...

For the first time ever, the five-year survival rate for all cancers combined has reached 70 percent. While it’s a moment to ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...